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The goal of surgery for the repair of abdominal
aortic aneurysm (AAA) is primarily to prevent rupture
of the aneurysm. Several techniques for AAA repair
have evolved during the last 40 years. Transabdominal
open endoaneurysmorrhaphy remains the gold stan-
dard by which other procedures have been mea-
sured.1-4 However, this technique may result in pro-
longed ileus, postoperative respiratory dysfunction,
increased third-space fluid losses, and increased phys-
iologic stress.5,6 Complications such as these in
patients who often have severe comorbid diseases has
stimulated interest in non-resective treatment of AAA
repair. This treatment was first attempted with distal
ligation and bypass grafting to reduce the long-term
risk of AAA rupture.7 Concurrent with this technique
was the reevaluation of the retroperitoneal approach
to aortic aneurysm repair.8-10 The use of exclusion of
the AAA sac and a retroperitoneal aortoiliac recon-
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Objective: The goal of abdominal aortic aneurysm (AAA) repair is the prevention of rup-
ture. Exclusion of the infrarenal AAA by means of operation or endovascular graft place-
ment is an alternative therapy to achieve this goal. However, thrombosis of the exclud-
ed aneurysm sac does not always occur and further intervention may be needed. This
study examines the efficacy of available screening methods to detect the persistence of
aneurysm sac flow and the outcome of secondary procedures to treat this problem.
Methods: During the past 14 years, 1218 patients have undergone operative retroperi-
toneal exclusion of AAA. To date, 48 patients have been found to have persistent flow
in the excluded AAA sac with duplex scanning. Twenty-seven patients underwent surgi-
cal intervention, and seven of these procedures were performed for rupture. Six patients
have undergone treatment with interventional techniques (four successfully). The
patients were evaluated for preoperative angiographic, anatomic, and comorbid factors
that may have predisposed them to failed exclusion. Also, perioperative morbidity and
mortality, estimated blood loss, and survival were assessed in the patients who required
surgical treatment.
Results: There were no perioperative parameters that correlated with postoperative per-
sistent flow in the excluded AAA sac. The mean time to secondary intervention was 51
months (range, 2 to 113 months). Two patients had false-negative computed tomo-
graphic angiogram results, eight patients had false-negative angiogram results, and six
patients had duplex scan examinations that had initially negative results that were then
positive for flow in sac. Reoperation had a 7.4% mortality rate (two deaths) and a medi-
an blood loss of 2600 mL, as compared with 500 mL for primary procedures.
Conclusion: Secondary operations for patent excluded aortic aneurysm sacs have higher
mortality and intraoperative blood loss rates than do primary procedures for AAA
repair. The localization of branch leaks with computerized tomographic angiography,
angiography, and duplex scanning were imprecise, and better methods are needed to ade-
quately diagnose patent sacs. Expansion of AAA sac may be the only reliable factor.
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struction has had excellent results at our institution.11
We observed decreases in postoperative stay and post-
operative ileus, early resumption of diet, and less
intense intensive care unit and postoperative care.
Theoretically, there are parallels between this tech-
nique and those of endovascular aortic stent grafting,
which is essentially endoluminal exclusion as opposed
to operative exclusion. The endovascular repair of
AAA with stent grafting may be less physiologically
stressful in the perioperative period. However, the
method still has the potential problem of persistent
flow in the aneurysm sacs, either by proximal, distal,
or aneurysm sac branch endoleaks.12-16 In this paper,
we will evaluate patients with excluded AAAs and
bypass grafts that have persistent flow in the AAA sac.
Also, we will analyze the results of various surveillance
techniques to detect for flow in the excluded
aneurysm sac after surgical exclusion and report on
the results for the secondary procedures to treat the
expansion of the excluded AAA sacs.
METHODS AND MATERIALS
All AAAs treated with retroperitoneal exclusion
and bypass grafting procedures that were performed
between 1984 and 1998 at the Vascular Institute were
reviewed. Vascular registry data, inpatient hospital
charts, and outpatient office charts were reviewed.
Demographics, operative indications, procedures per-
formed, flow, and size of the excluded AAA sac were
recorded. Also, the localization of feeding vessels and
the results of secondary procedures to alleviate sac
flow and expansion were evaluated.
During this 14-year period, 1218 patients under-
went operative exclusion of AAA. This number was
approximately two thirds of the patients who under-
went AAA repair. The remaining one third underwent
converted open endoaneurysmorrhaphy because of
surgeon preference or inability to technically perform
exclusion (ie, short aortic neck). The methods of eval-
uation of the abdominal aorta sac were as follows: all
the patients underwent follow-up duplex scanning at
3, 6, and 12 months, every 6 months for 2 years, and
yearly thereafter. Ninety-two percent of the patients
underwent one duplex ultrasound scan examination,
87% underwent two to four examinations, and 83%
had complete follow-up examinations. The studies
with positive results exhibited increased aortic sac
size, wall motion, or flow in sac. To date, 48 patients
have been found to have positive duplex examination
results of excluded AAA sacs. The surgical technique
for AAA exclusion and bypass grafting has been previ-
ously described.10,11 Briefly, the clamps were placed
on the infrarenal aorta and the aortic neck was tran-
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sected and oversewn distally. Next, the distal aorta or
iliac vessels were oversewn and an aortic bypass graft-
ing procedure was performed. Excluded sacs were
checked for flow at the time of operation. Those
patients who, at follow-up examination, had an
expansion of the AAA sac or symptoms of aneurysm
sac expansion, such as back or abdominal pain, under-
went further evaluation with three-dimensional com-
puted tomographic (CT) angiography, magnetic res-
onance angiography, contrast angiography, or a com-
bination of the aforementioned. The patients with
persistent flow but no expansion of the aneurysm sac
were followed until the aneurysm grew (>1 cm from
preoperative study). Secondary operations were pref-
erentially performed through a lower midline incision
to allow access to the excluded aneurysm sac and to
both common iliac arteries. The common iliac arter-
ies were controlled externally as necessary, and then
the sac was opened. The lumbar vessels, the inferior
mesenteric artery, and the other feeding vessels were
ligated. The sac was left open, and the posterior peri-
toneum and the midline incision were closed.
RESULTS
The 30-day operative mortality rate for all the
patients who underwent exclusion and bypass graft-
ing was 3.4%. The mortality rate of the elective pro-
cedure was 2.4%, and the rate for the emergent pro-
cedures was 14.3%. Myocardial infarction accounted
for 50% of the deaths. Other causes of death were:
acute respiratory distress syndrome (30%), stroke
(10%), colon ischemia (1.5%), renal failure (5%), and
coagulopathy (3.5%). The median estimated blood
loss at the time of operation was 500 mL. Blood
transfusions were required in approximately 30% of
the patients. At the time of exclusion, persistent flow
was evaluated with palpation of the aneurysm sac,
with insonnation with a hand-held Doppler scan
instrument, and occasionally with pressure measure-
ments. If flow was noted, the lumbar arteries were
ligated, as was the inferior mesenteric artery, and the
ligated iliac vessels were rechecked to document ade-
quate ligation. As mentioned, 48 patients had per-
sistence of flow or enlargement in the aneurysm sac.
This flow was detected at a range of 1 month to 113
weeks, with a mean time to secondary intervention
of 51 months. Forty-four of 48 patients had persis-
tent flow, and 28 of 44 patients had excluded AAA
sac enlargement. The demographics for the group of
patients with persistent flow and for those who
underwent treatment with exclusion bypass grafting
who did not have persistent flow were not statisti-
cally different. The type of reconstruction used in
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patients who had persistent expansion of the sac
showed slightly more bifurcated reconstruction, but
this was not significant (Table I). Twenty-seven
patients underwent surgical intervention, and seven
procedures were performed for the rupture of
excluded sac. Three of the seven patients with rup-
tured AAA sacs were lost to follow-up examination,
and the remainder was seen with sudden expansion
after being followed for persistent flow without
enlargement. In addition, four of six patients under-
went successful treatment with interventional tech-
niques. Two common iliac arteries and two hypogas-
tric arteries were coiled successfully, and two mid-sac
branch leaks could not be successfully treated. Of
the patients who underwent surgical treatment,
there were two deaths (7.4%). The median blood
loss was 2600 mL, with a range of 700 mL to 10 L.
The anatomic distribution of inflow vessels to the
patent sac are listed in Table II.
Duplex scan screening was the primary method
of follow-up examination. The duplex scan results
showed that six patients had no flow by means of
duplex scan originally and that flow developed in the
long term. Fourteen patients underwent further eval-
uation with CT angiography, and two of the 14
demonstrated no flow despite persistent enlargement
of the aortic sac and flow at the time of sac evacua-
tion (operation). Twenty-five patients underwent
further evaluation with selective visual angiography
with delayed images. Eight of these angiograms did
not reveal feeding vessels to the aneurysm sac, and
the remaining 21 did show feeding vessels. All the
patients with positive test results demonstrated either
enlargement of the AAA sac or wall motion and flow
within the sac. Seventeen patients are currently being
followed because they are asymptomatic and the
aneurysm sac has not increased in size, with a sensi-
tivity of angiography of 68% (17 of 25) and CT
angiography of 86% (12 of 14).
The patients who had persistent aortic sac flow
underwent evaluation for the following periopera-
tive risk factors: concomitant occlusive disease, num-
ber of patent lumbars on angiography at original
operation, use of long-term anticoagulation therapy,
and aneurysm size. These factors in the persistent
flow group were evaluated against a cohort of 100
consecutive patients who did not have persistent
flow. There was no statistical difference between any
of the groups, although the number of those
patients who required long-term anticoagulation
therapy approached significance (P = .056). The
interval for presentation from the time of original
surgery to the time of intervention for symptomatic
persistent sac flow are listed in Table III.
DISCUSSION
The operative repair of AAA traditionally has
involved open aneurysmorrhaphy with in-line graft
replacement, which often subjects the patient to sig-
nificant blood loss and perioperative physiologic
stress.1,5,6 The retroperitoneal exclusion technique
allows for less physiologic stress to the patient and
decreases blood loss, and some investigators find it to
be a technically easier procedure.5,6,11 However, the
goal of AAA repair is primarily the prevention of the
aneurysm sac from expansion and rupture, and, to
Table I. Demographics and type of reconstruction
No. of exclusions No. of exclusions
with leak without leak
Total 48 1170
Demographics
Male 40 (83.3%) 908 (77.6%)
Female 8 (16.7%) 262 (22.4%)
Diabetic 5 (10.4%) 111 (9.5%)
Smoker 10 (20.8%) 411 (35.1%)
Mean age (years) 72 71
Age range (years) 52 to 90 41 to 92
Reconstruction type
Tube graft 3 (6.3%) 163 (13.9%)
Aortobiiliac 40 (83.3%) 754 (64.4%)
Aortobifemoral 3 (6.3%) 110 (9.4%)
Aortoiliac-femoral 2 (4.2%) 143 (12.2%)
Table III. Vessels that feed the excluded abdomi-
nal aortic aneurysm sac and times of intervention
No. of ligated No. of ligated
Time lumbar/interior iliac/lumbar Embolization
(months) mesenteric arteries arteries of sac
0 to 12 2 1 2
13 to 24 1 1 2
25 to 36 2 4
37 to 60 4 6
61 to 84 2 2
85 to 108 2
109 to 132
Total 11 16 4
Table II. Primary source of flow at operation
Source of flow No. of operations
Inferior mesenteric artery 6
Lumbar artery 19
Iliac artery 6
consider an exclusion and bypass grafting procedure
a technically successful operation, one has to eventu-
ally thrombose the aneurysm sac. Unfortunately,
approximately 4% to 7% of patients had persistent
flow after exclusion and, even in some cases, rupture
of the excluded sac. This represents a failure of the
exclusion technique. The predictive measures of
those patients who did not have induced thrombosis
of their AAA sac may be of value in the future for
patients who undergo either surgical or endovascular
exclusion of AAAs. The population of patients with
persistent flow in the sac in this present study had
similar demographics when compared with the other
patients who underwent AAA repair. The only risk
factor that was found to approach statistical signifi-
cance for persistent flow was the patients who were
undergoing long-term oral anticoagulation therapy
with warfarin sodium. Collateral circulation was eval-
uated on preoperative angiography and was similar in
the patients who had postoperative AAA sac throm-
bosis and in those who had persistent flow in the
aneurysm sac.
In our series, seven excluded aortic aneurysm
sacs went on to rupture. Of even more concern,
however, is the fact that three of the seven had been
lost to follow-up examination before presentation.
This resulted in one death after the ensuing sec-
ondary procedure. A second death occurred in a
patient who was coagulopathic despite having
undergone exploration three times for persistent
bleeding from the aneurysm sac. Despite an aggres-
sive intraoperative effort with Doppler scanning and
intraluminal pressure measurements to identify
those sacs at risk for postoperative patency, we still
found 48 patients who had persistent flow in long-
term follow-up examination. In a prospective ran-
domized study by Paty et al17 that compared exclu-
sion with open endoaneurysmorrhaphy, 12 of 49
patients who underwent exclusion had to undergo
ligation of lumbar, iliac, or inferior mesenteric arter-
ies to fully isolate the sac from the systemic circula-
tion. After this study, we became more aware of the
need to fully exclude the ligated AAA sac from the
systemic circulation, such as lumbar, hypogastric,
and other feeding arteries. This is not inconsistent
with the data that were recently published for mid-
graft branch artery endoleaks in patients who under-
went endoluminal graft treatment.18-21 Fortunately,
some of these patients may eventually thrombose
their collateral circulation to the sac within 6
months. However, there is still concern over when
to intervene in patients with persistent flow in the
aortic sac. We took a rather conservative stance
because we only intervened in those patients who
demonstrated expansion of their sac or who had
symptoms. In doing so, we essentially evaluated the
natural history of the patients with persistent flow.
Seven of the patients were first seen with rupture.
There were no intraoperative deaths. However, the
30-day mortality rate was substantially higher than
the rate in those patients who underwent elective
operation. The incidence of rupture after exclusion
is consistent with the rates reported in the literature
for endovascular grafts. Chuter et al22 reported two
of 57 patients with aneurysm rupture in the early
postoperative period after endograft placement, and
Broeders et al23 reported two of 26 patients with a
rate of expansion of 0.3 mm per month in patients
who had persistent endoleaks. Also, Walker et al20
demonstrated that the number of patent lumbar
arteries was not predictive of subsequent endoleak,
and this was corroborated by other investiga-
tors.18,19,21 Furthermore, Torsello et al24 described
a patient undergoing warfarin sodium therapy who
had a rupture of an aneurysm from expansion of the
sac after endograft placement.25 This again is cor-
roborated by our data, which showed that patients
undergoing chronic anticoagulation therapy may be
at a higher risk for persistent flow and possible rup-
ture after exclusion. In their seminal paper, Wain et
al13 classified endoleaks after endovascular graft
placement, and they found that, although there was
a higher rate of patients with endoleaks with aortoil-
iac occlusive disease and patent side branches, the
data were not statistically significant.13 Chuter et
al26 and Schurink et al18 have tried to correlate pres-
sure measurements and endoleakage in excluded
aneurysms after stent graft placement. The latter
group also demonstrated that even small endoleaks
can cause pressure in the excluded sac that is greater
than systemic diastolic pressure. Furthermore, these
endoleaks were not well visualized on digital sub-
traction angiography and CT angiography. The
authors had much better success visualizing these
small endoleaks with delayed CT angiographic pro-
tocol.18 In our study, despite this type of delayed
evaluation, two patients who had increasing exclud-
ed AAA sacs had voluminous flow at surgery yet no
detection on delayed CT angiography.
In this study, the most reliable method for the
detection of persistent flow in the aneurysm sac was
duplex scanning. Most patients demonstrated throm-
bosis of the sac with a decrease in aneurysm sac size.
However, the patients with no shrinkage of AAA sac,
and especially with expansion in the size of the sac,
obviously were at high risk for expansion and possible
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rupture. Even more disturbing, a subset of patients
had negative duplex scan examination results in
immediate follow-up examinations but had flow
develop in subsequent examinations and even had
expansion of their aneurysm. Two of these patients
originally demonstrated shrinking of their aneurysm
and then further expansion in the long-term follow-
up period. Also of note is that the average time from
original operative to secondary intervention was more
than 4 years. According to our data, one may not see
the problems with persistent flow in the excluded
aneurysm sac until late in the follow-up period. At
present, the most logical recommendation for any
patient who undergoes exclusion of aneurysm is that
they undergo consistent long-term, if not life-long,
follow-up examination to evaluate the efficacy of the
exclusion of their aortic aneurysm sac. One may argue
that the preoperative ablation of the inferior mesen-
teric artery and the lumbar arteries may obviate the
need for long-term follow-up examination and obvi-
ate the potential of expansion of the sac. However,
Broeders et al23 evaluated the patency of the inferior
mesenteric artery and the lumbar arteries in the inci-
dence of endoleak after the endovascular repair of
infrarenal AAA. Again, they found that the number of
patent lumbar vessels was not predictive of endoleak,
and they stated that if a policy of preoperative
embolization on the basis of large patent lumbar
arteries had been adopted, 78% of the patients would
have undergone unnecessary procedures.22 Also,
other investigators have reported significant compli-
cations, such as paralysis and bowel ischemia, after
multiple interventions and attempts at embolization
of the inferior mesenteric and lumbar arteries before
surgery, and thus, most centers have not adopted this
as standard routine.27,28
CONCLUSION
AAA repair with the exclusion technique is not 
a definitive procedure. The localization of the
aneurysm sac branch leaks with CT angiography,
contrast angiography, and duplex scanning was
imprecise. Secondary operations for patent excluded
AAA sacs have higher mortality and intraoperative
blood loss rates than do primary procedures for AAA
repair. Expansion of AAA sacs as seen on postopera-
tive surveillance may be the only reliable factor that
we presently have to evaluate persistent flow and
minimize long-term complications, such as rupture.
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Dr Takao Ohki (Bronx, NY). Some 4 years ago, when
I presented my first paper at the Eastern Vascular Society
meeting, Dr Darling was my discussant. It is my great
honor to be able to discuss his paper now, and I would like
to thank the organization for giving me this opportunity.
This study represents another landmark paper from a
group that has been both a leader in and a strong advocate
of exclusion repair of abdominal aortic aneurysm (AAA).
It provides enormous insights into both open and
endovascular treatment of AAA, because the exclusion
technique, which leaves the aneurysm intact with patent
side branches, creates a great model to better understand
the natural history of AAA treated endovascularly.
Dr Darling has reviewed more than 1200 cases of
patients who underwent operative retroperitoneal exclu-
sion of AAA and found that 48 patients have persistent
flow within the excluded sac with duplex scan examina-
tion. Patients with an enlarging sac or those who became
symptomatic underwent treatment with reoperation or
interventional techniques. They concluded that reopera-
tion carried an increased mortality rate and that postoper-
ative localization of branch leaks was imprecise no matter
what technique. Finally, Dr Darling concluded that the
exclusion technique is not a definitive treatment.
I have several questions for Dr Darling. On the basis
of this conclusion, that it is not a definitive treatment, are
you suggesting that we abandon this procedure, a proce-
dure that you and your group have advocated as the gold
standard operation and popularized? I personally started
to use your technique in Japan after watching some of
your videotapes, and I am sure I am not the only one in
this room who has done so. Therefore, your comments
regarding this procedure have a strong impact on what we
do tomorrow.
In your previous paper11 in the Journal of Vascular
Surgery published in 1992, you state that “exclusion tech-
nique is an efficient treatment for AAA.” Having said that
exclusion technique is not a definitive treatment, do you
still think the same way now?
In addition, please comment on your thoughts on
retroperitoneal approach and endoaneurysmorrhaphy
instead of exclusion technique. I ask this because a small
prospective randomized trial that compared retroperi-
toneal endoaneurysmorrhaphy and transabdominal
approach published by Dr Sicard also showed early recov-
ery, less complication, shorter length of hospital stay, and
lower cost for retroperitoneal approach, much like your
previous study published by Dr Paty.17 The retroperi-
toneal endoaneurysmorrhaphy, as opposed to exclusion,
however, did not suffer from persistent perfusion.
As you pointed out, both endovascular repair and your
exclusion technique are not definitive and require life-long
surveillance. However, the endovascular repair can be per-
formed in a less invasive fashion as compared with your
exclusion technique, as shown by the short length of hos-
pital stay that now ranges from 1 to 3 days, which is not
the case with your retroperitoneal exclusion technique. Is
your operation, the exclusion technique, taking the worst
of both worlds? Is it an operation that is almost as invasive
as transperitoneal repair, yet is almost as nondurable as
endovascular repair?
Can you let us know what happened to the size of the
aneurysms that did not have persistent flow. Did they
shrink in size? Did any of them grow in size despite lack of
persistent flow? This is a well-recognized condition after
endovascular repair and is now termed endotension, which
also can lead to rupture.
You have divided the source of leak into either iliac
DISCUSSION
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artery, lumbar, or inferior mesenteric artery. In the field of
endovascular repair, the iliac leak will be classified as a type
1 leak and the lumbar or inferior mesenteric artery as a type
2. Most of us believe that the type 1 leak is more harmful
than the type 2, the retroleak, because it provides prograde
flow and high pressure. Of those seven patients whose
aneurysms ruptured, did you find more iliac leak as opposed
to other sources? And how many of the 17 patients with a
persistent flow but without aneurysm enlargement who are
observed have iliac leak or type 1 leak?
Recently, we treated one of your patients who pre-
sented with an expanding pulsatile abdominal mass after
exclusion repair. The leak originated through the spaces
between the sutures placed to occlude the common iliac
artery. The repair of this leak was performed by simply
placing several embolization coils into the space between
sutures. The strong pulsation of the aneurysm resolved
immediately, and the patient left the hospital the same day.
In contrast to this single experience, the estimated
blood loss, morbidity, and mortality rate were higher for
the second operation as compared with the first one in
your paper. And I am a bit puzzled why the second oper-
ation was so difficult. Is it because you included seven rup-
tured cases in your second operation, whereas the first
operation was performed only for elective cases? In elec-
tive reoperation, because you already have the bypass graft
placed, all you have to do is to expose the aneurysm
through a virgin field and ligate the source of the leak.
Why is this procedure so much more risky than the initial
procedure? What are the specific things that made this sec-
ond operation complicated?
I thank Dr Darling for giving me the opportunity to
read this excellent paper. I learned a great deal from it.
Dr R. Clement Darling III. Thank you for your
insightful and excellent comments. I will try to take them
one at a time.
Whenever you change a technique and try to improve
it, you have to be willing to take the fall when you do not
think it is working well. And I think that is what we have
decided to do with the exclusion technique. Our goal
originally was to try to minimize operative trauma by per-
forming a technique that would minimize the blood loss,
especially when you open the aneurysm. Unfortunately, in
27 patients, we found that we would have to go back and
revisit that trauma.
Currently, we are not performing any more exclusion
techniques. We are performing all retroperitoneal expo-
sures of the aorta. And one of the beauties we have
learned, especially from Dr Paty’s prospective, randomized
study,17 is that if you go in retroperitoneally and clamp
distally and then proximally, you can pick off all the lum-
bar arteries and the inferior mesenteric artery and then
open the aneurysm and do a standard endoaneurysmor-
rhaphy with minimal blood loss.
As we have embarked in the placements of endografts,
we were trying to use some of this information that we
gleaned from the 14 years of experience with this proce-
dure. Hopefully, this will pan out in the long run.
One of the main benefits of the retroperitoneal
approach to the aorta is that one can ligate the lumbars
through this approach more easily than with transabdom-
inal exposure.
As far as definition of endoleaks or endotension, I think
all of us who use endovascular grafting have gotten some-
what Clintonian in our description of endoleaks. And one
man’s porosity is another man’s leak. Any time the aneurysm
sac grows, there is a leak there—you just cannot find it. And
so it is not the aneurysm sac’s fault for getting bigger, it is
our current inability to identify the source. We have to
assume that it has flow in the sac and that we have to find
some way to better identify it and attack it endovascularly if
we can, which may hold the minimal amount of disturbance
for the patient. But if we cannot, then I think we just have
to take the battle up front and perform an open operation.
As far as the endoleaks go, they were type 2 endoleaks
in those patients whose aneurysms ruptured. And as a mat-
ter of fact, the iliac leaks were much easier to deal with than
the mid-branch leaks. We tried to control the iliac leaks
externally before we opened the aneurysms. And those were
the patients, if the leaks were solely on the basis of that, in
whom we could control the bleeding.
The bleeding from these secondary operations came
from two different problems. We used a lower midline
incision. So, therefore, it was very difficult to get control
of the lumbar arteries externally. And if there were more
than a couple of pairs of lumbar arteries, those vessels
could bleed rather vigorously. You do not have the luxury
of having a wider field because the graft may limit your
exposure. Thus, you have all the disadvantages of a mini-
mally invasive procedure, and you can lose a lot of blood
in a small area very quickly. I think that is what established
our increased blood loss.
Also, these sacs became somewhat neovascularized.
And the whole walls in the vasa vasorum were very dilat-
ed and were under more pressure than you would think
possible. This also added to the blood loss during these
operations. I think once you get through the blood loss,
most of the postoperative complications were similar to
most midline transabdominal operations.
Unfortunately, I think Dr Ohki is right, we did have the
worst of both worlds. In the endografts, you have a small
morbidity and very little physiologic disturbance up front,
especially as you have gone past your learning curve, but we
had the problems of an open operation and then the long-
term problems of a nondefinitive operation, and that has
entered into the fact of why we are changing our approach.
Dr Ohki. Reading your manuscript, it is not clear that
you have abandoned this technique. I urge you to write
that in your manuscript because today’s audience is small
and the rest of the world should be informed also.
Dr Darling. Thank you.
Dr Roy K. Greenberg (Rochester, NY). I think that
was a fascinating paper. It is a bit humorous to recall many
of the articles on animal models for type 2 endoleaks. It
appears that in Albany you have a human model to do that.
My question for you relates to the larger number of
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patients you treated surgically. Would you elaborate on how
you chose when to treat some patients with embolization
techniques and others operatively? And as a follow-up, were
any of these aneurysms pulsatile on physical examination?
Your data clearly contradict the concept that all type 2
endoleaks are benign. It would be nice to try to define some
risk factors for continued aneurysmal growth in your large
patient population. The implications for patients who under-
go treatment with an endovascular approach are clear. I look
forward to hearing more as your follow-up time increases.
Dr Darling. Thank you, Dr Greenberg. I know your
group is very active in endografting. There were a few
patients who, unfortunately, had pulsatile aneurysm sacs
develop. Most of those patients, though, have retrograde
leaks from the iliac arteries. And, as in the one patient Dr
Ohki has just treated, it was not pulsatile when the patient
left the hospital, but, in long-term follow-up examination,
either the iliac ligation in continuity that was used to lig-
ate the right common iliac loosened or the vessel dilated.
Either way, there was flow into the right iliac system.
We were very conservative in the treatment of these
patients because I think we took the same kind of ostrich
approach that a lot of people do in endografts when we
started the procedure. We did the bypass grafting, and we
thought that the low flow would thrombose the aneurysm
in the long term. We kept following the patients as long as
they were not symptomatic or as long as the aneurysm sac
did not grow. The most disturbing part of this was that we,
as most people do, lost some patients to follow-up exami-
nation. And of the seven ruptures, two of them were in
patients who were lost to follow-up examination. And
again, that, plus the flow data, made us move away from
the use of the exclusion technique as a preferred technique.
Dr Ohki. How many patients died after the seven
ruptures?
Dr Darling. The patients with ruptures actually did
not die. There was one patient who died who we explored
three times just to try to control different bleeding sites.
Dr Ohki. And that was not rupture?
Dr Darling. And that was not a rupture. His proce-
dure was elective.
Dr Ohki. So, the mortality rate after rupture was?
Dr Darling. Actually the mortality rate from the rup-
ture was 0%.
Dr Ohki. So, that confirms what Dr May had pub-
lished—that is, a patient whose aneurysm ruptures after
endovascular repair has a much better outcome as com-
pared with a de novo rupture. I think your rupture is sim-
ilar to endovascular rupture, and it is a lot different from
the de novo rupture in which we find a mortality rate from
50% to 70%.
Dr Darling. That may be true. It is a slow death versus
a quick death. But either way, it is not what I would con-
sider to be the optimal therapy. But I agree, I think they
are under a lower pressure. And there were some studies
by Tim Chuder26 that showed that even these branch leaks
can exceed the diastolic flow in the aorta and you can pro-
ceed on to rupture.
Dr Peter J. Pappas (Newark, NJ). I rose because I am
going to remember this presentation as a profile in courage.
I think you have a tremendous amount of integrity for
someone whose group has proposed this operation. You
have studied it, you have looked at it, and you have come to
the conclusion that it may not be the most optimal opera-
tion. I think that is just a rare thing to see, and I would like
to compliment you on that.
The other two things for which I will remember this
presentation is the use of duplex ultrasound scanning. I
cannot recall very many of the endovascular papers that
use duplex scanning to look for endoleaks. And I think it
is such a common sense thing to do, but yet I do not know
why we have not been doing it. We have been depending
on computed tomographic scans to look for endoleaks in
all of our trials. And perhaps maybe we should be using
simpler, less expensive techniques to do that. And then, of
course, the most obvious thing is the endovascular inves-
tigators will be looking at your rupture rate as a model for
what endoleaks will do, and I think it is going to really stir
a lot of interest in this topic.
I just want to congratulate you again. I think you have
a tremendous amount of courage.
Dr Darling. Thanks very much, Peter, for those amaz-
ingly kind comments. You know, if you live by the sword,
you are going to die by the sword in this business. And I
think that everybody is obligated to, objectively, look at
their data. We try to improve on our current techniques,
and unless you can really objectively analyze it, I think
there is no benefit in doing it.
The duplex scan has worked extremely well for us. We
have an excellent laboratory run by Anna Marie Kupinski,
and it has been very good in following these patients. The
biggest concern I think we have is losing these patients to
follow-up examination because they are patients who will
convert from negative study results to positive study
results. And so I think the onus is on us to make sure that
these patients get treated effectively and quickly. What we
are doing presently is reviewing all the patients and calling
the ones that have leaks.
Dr Enrico Ascher (Brooklyn, NY). I really enjoyed the
presentation. I just want to follow up on the last comment.
How are you going to make sure that the patients that have
undergone this procedure actually know of your results?
Second, are you feeling a little bit threatened that some
of these patients may not be as enthusiastic as Dr Pappas
about your results? How are you going to go about that?
Because we also have attempted to do some procedures, we
always have that in the back of our mind: some of the oper-
ations that we started some time ago worked, and some did
not. And we are always getting by without really facing some
of the scrutiny that the companies who put products in the
market are passing by. So, I just want to know, what do you
do about that, and what do you suggest we should all do?
Dr Darling. That is a difficult problem. Obviously, it
was not pleasant to go to the 27 patients and tell them,
“You remember how we fixed your aneurysm? It is not
fixed.” But it is the same informed consent you give all your
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patients in whom you do endografts. Because honestly you
have to tell them that there is a chance of persistent flow,
there is a chance of migration, and there is a chance of these
complications.
As we went further on, we said to most of the patients
that they may have to be followed for the rest of their lives
and that they may end up with another operation, but that
the risks were fairly low.
Dr Robert Cohen (Newark, NJ). I just have a quick
question on this. After you have tied off the aneurysm sac
and excluded it, you have time to end the graft, because then
you have time to do whatever it is you want to do with other
bleeding and maybe potential leaks. Why not do angiogra-
phy, actually, of the excluded sac or use ultrasound scanning
during surgery to look for where those potential endoleaks
might occur and then do whatever you need to do—dissect
it out, put a clip on it, tie it, or something like that?
Dr Darling. That is a good point. When we did the
prospective, randomized study, one of the most disheart-
ening points of it was that of those patients we excluded,
for 12, almost about 20% of them, we had to go back and
ligate the lumbar arteries at the time of operation. We were
taking pressure measurements, we were listening with a
Doppler scan, and we were trying to make sure that the
flow was completely occluded. So, I think that was the
beginning of the point where we decided that maybe even
with just tying off the arteries proximally and distally you
were not fully excluding the aortic sac. So, once we started
doing that, then we started clipping all the lumbar arteries,
clipping the inferior mesenteric artery, and clipping the
median sacral. And then we said: Why do we not just open
it? So, that is how we evolved back into the technique that
has been going on for 40 years. And you can do that with
a good 300 mL or 400 mL blood loss in most cases.
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